Open access
69
Views
3
CrossRef citations to date
0
Altmetric
Original Research
Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug
Jason R Guertin1 CHUM Research Center, Montréal, QC, Canada;2 Programs for Assessment of Health Technology in Health Research Institute, Hamilton, ON, Canada
, Dominic Mitchell1 CHUM Research Center, Montréal, QC, Canada;3 Logimétrix Inc., Repentigny, QC, Canada
, Farzad Ali4 Pfizer Canada Inc., Kirkland, QC, Canada
& Jacques LeLorier1 CHUM Research Center, Montréal, QC, CanadaCorrespondence[email protected]
Pages 497-503
|
Published online: 06 Oct 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.